GPP
Great Point Partners Portfolio holdings
AUM
$154M
This Quarter Return
-8.21%
1 Year Return
-2.36%
3 Year Return
+169.3%
5 Year Return
+292.82%
10 Year Return
+3,519.88%
AUM
$222M
AUM Growth
+$222M
(+1.2%)
Cap. Flow
+$16.7M
Cap. Flow
% of AUM
7.51%
Top 10 Holdings %
Top 10 Hldgs %
57.18%
Holding
48
New
9
Increased
13
Reduced
8
Closed
11
Top Buys
| 1 |
ELGX
Endologix Inc
ELGX
|
$8.27M |
| 2 |
Aurinia Pharmaceuticals
AUPH
|
$7.92M |
| 3 |
Exelixis
EXEL
|
$7.8M |
| 4 |
OCRX
Ocera Therapeutics, Inc.
OCRX
|
$7.66M |
| 5 |
Vericel Corp
VCEL
|
$6.18M |
Top Sells
| 1 |
THOR
THORATEC CORPORATION
THOR
|
$9.03M |
| 2 |
AMBI
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
|
$6.99M |
| 3 |
Arcturus Therapeutics
ARCT
|
$5.76M |
| 4 |
Neurocrine Biosciences
NBIX
|
$5.49M |
| 5 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$4.26M |
Sector Composition
| 1 | Healthcare | 74.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HPTX
1
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
| $20M | 8.6% | 793,864 +135,880 | +21% | +$3.43M |
|
|
2
Neurocrine Biosciences
NBIX
$13.8B
| $18.2M | 7.82% | 1,161,739 -350,364 | -23% | -$5.49M |
|
|
INFI
3
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $14.8M | 6.34% | 1,100,000 +141,400 | +15% | +$1.9M |
|
|
ALIM
4
DELISTED
Alimera Sciences, Inc.
ALIM
| $14.2M | 6.1% | 2,619,853 +1,009,537 | +63% | +$5.47M |
|
|
ISEE
5
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $11.7M | 5.02% | 300,000 +49,900 | +20% | +$1.94M |
|
|
ELGX
6
DELISTED
Endologix Inc
ELGX
| $10.3M | 4.43% | 973,200 +779,918 | +404% | +$8.27M |
|
|
DSCI
7
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $9.68M | 4.16% | 1,161,604 +13,312 | +1% | +$111K |
|
|
ARDM
8
DELISTED
Aradigm Corp Common Stock
ARDM
| $9.67M | 4.15% | 1,008,062 | – | – |
|
|
AMBI
9
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $9.24M | 3.97% | 600,000 -453,895 | -43% | -$6.99M |
|
|
OCRX
10
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $9.11M | 3.91% | 1,859,315 +1,562,371 | +526% | +$7.66M |
|
11
Orthofix Medical
OFIX
$592M
| $8.2M | 3.52% | 264,873 -35,827 | -12% | -$1.11M |
|
|
12
Aurinia Pharmaceuticals
AUPH
$1.58B
| $7.92M | 3.4% | +2,474,076 | New | +$7.92M |
|
|
13
Exelixis
EXEL
$10.1B
| $7.8M | 3.35% | +5,100,000 | New | +$7.8M |
|
|
CASC
14
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $7.5M | 3.22% | 3,907,952 +3,116,152 | +394% | +$5.98M |
|
15
Cassava Sciences
SAVA
$110M
| $7.11M | 3.05% | 1,817,889 +123,633 | +7% | +$483K |
|
|
16
Vericel Corp
VCEL
$1.83B
| $6.19M | 2.66% | +2,170,000 | New | +$6.18M |
|
17
Emergent Biosolutions
EBS
$443M
| $6.18M | 2.65% | +290,000 | New | +$6.18M |
|
18
Veracyte
VCYT
$2.39B
| $5.92M | 2.54% | 607,296 +146,086 | +32% | +$1.42M |
|
|
HTWR
19
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $5.43M | 2.33% | +70,000 | New | +$5.43M |
|
20
Achieve Life Sciences
ACHV
$152M
| $4.79M | 2.06% | 1,793,942 -317,648 | -15% | -$848K |
|
|
SPHS
21
DELISTED
Sophiris Bio, Inc.
SPHS
| $4.65M | 2% | 1,585,500 | – | – |
|
22
Tenax Therapeutics
TENX
$27.3M
| $4.38M | 1.88% | 1,115,497 -1,000,000 | -47% | -$3.93M |
|
|
FRTX
23
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $3.39M | 1.46% | 3,025,000 +934,046 | +45% | +$1.05M |
|
|
CUTR
24
DELISTED
Cutera, Inc.
CUTR
| $3.18M | 1.37% | 315,000 +11,287 | +4% | +$114K |
|
|
ANTH
25
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $2.75M | 1.18% | 1,431,196 -68,804 | -5% | -$132K |
|